ANS Bücher von OLG Mitgliedern

Weitere Bücher

  • Christopher J. Mathias, Sir Roger Bannister [Editors]
    Autonomic Failure: - A Textbook of Clinical Disorders of the Autonomic Nervous System
    Oxford University Press, 2013
    doi.org/10.1093/med/9780198566342.001.0001
  • Phillip A. Low and Eduardo E. Benarroch [Editors]
    Clinical Autonomic Disorders, Third Edition
    Lippincott Williams & Wilkins, 2008
  • David Robertson, Italo Biaggioni, Geoffrey Burnstock, Phillip A. Low , Julian F. R. Paton [Editors]
    Primer on the Autonomic Nervous System, Third Edition
    Academic Press, 2012
  • Günther Deuschl, Wolfgang H. Oertel, Werner Poewe [Herausgeber]
    Parkinson-Syndrome und andere Bewegungsstörungen, 2.Auflage
    Thieme 2020
    www.thieme.de/shop

ANS Publikationen von OLG Mitgliedern

2024 (bis Juni 2024)

  • Cavallieri F, Sellner J, Akhvlediani T, et al. The European Academy of Neurology NeuroCOVID-19 Task Force: A lesson for the future. Eur J Neurol 2024:e16321. https://doi.org/10.1111/ene.16321.
  • Cheng A, Jia W, Finkelstein DI, et al. Pharmacological inhibition of FABP7 by MF 6 counteracts cerebellum dysfunction in an experimental multiple system atrophy mouse model. Acta Pharmacol Sin 2024;45:66-75. https://doi.org/10.1038/s41401-023-01138-y.
  • Chia R, Ray A, Shah Z, et al. Genome sequence analyses identify novel risk loci for multiple system atrophy. Neuron 2024. https://doi.org/10.1016/j.neuron.2024.04.002.
  • Fanciulli A, Krismer F, Struhal W, Stefanova N. Gregor K. Wenning: a brilliant mind. Clin Auton Res 2024. https://doi.org/10.1007/s10286-024-01043-2.
  • Fanciulli A, Stankovic I, Avraham O, et al. Early Screening for the Parkinson Variant of Multiple System Atrophy: A 6-Item Score. Mov Disord Clin Pract 2024. https://doi.org/10.1002/mdc3.14048.
  • Fedorowski A, Fanciulli A, Raj SR, Sheldon R, Shibao CA, Sutton R. Cardiovascular autonomic dysfunction in post-COVID-19 syndrome: a major health-care burden. Nat Rev Cardiol 2024;21:379-395. https://doi.org/10.1038/s41569-023-00962-3.
  • Heim B, Mandler E, Buchmann A, et al. Serum Neurofilament Light and Clinical Biomarkers for Disease Staging in Huntington's Disease. Mov Disord Clin Pract 2024. https://doi.org/10.1002/mdc3.13993.
  • Kawabata K, Krismer F, Heim B, et al. A Blinded Evaluation of Brain Morphometry for Differential Diagnosis of Atypical Parkinsonism. Mov Disord Clin Pract 2024;11:381-390. https://doi.org/10.1002/mdc3.13987.
  • Krismer F, Peran P, Beliveau V, et al. Progressive Brain Atrophy in Multiple System Atrophy: A Longitudinal, Multicenter, Magnetic Resonance Imaging Study. Mov Disord 2024;39:119-129. https://doi.org/10.1002/mds.29633.
  • Leys F, Eschlbock S, Campese N, et al. Sex-related differences in the clinical presentation of multiple system atrophy. Clin Auton Res 2024;34:253-268. https://doi.org/10.1007/s10286-024-01028-1.
  • Millar Vernetti P, Norcliffe-Kaufmann L, Palma JA, et al. Phenoconversion in pure autonomic failure: a multicentre prospective longitudinal cohort study. Brain 2024. https://doi.org/10.1093/brain/awae033.
  • Ndayisaba A, Pitaro AT, Willett AS, et al. Correction to: Clinical trial-ready patient cohorts for multiple system atrophy: coupling biospecimen and iPSC banking to longitudinal deep-phenotyping. Cerebellum 2024;23:52-53. https://doi.org/10.1007/s12311-022-01501-5.
  • Ndayisaba A, Pitaro AT, Willett AS, et al. Clinical Trial-Ready Patient Cohorts for Multiple System Atrophy: Coupling Biospecimen and iPSC Banking to Longitudinal Deep-Phenotyping. Cerebellum 2024;23:31-51. https://doi.org/10.1007/s12311-022-01471-8.
  • Nicholson L, Piras IS, DeBoth MD, et al. Transcriptomic insights into multiple system atrophy from a PLP-alpha-synuclein transgenic mouse model. Brain Res 2024;1834:148912. https://doi.org/10.1016/j.brainres.2024.148912.
  • Olbert E, Alhani N, Struhal W. Retrospective analysis of COVID-19 patients with Guillain-Barre, Miller-Fisher, and opsoclonus-myoclonus-ataxia syndromes-a case series. Wien Med Wochenschr 2024;174:30-34. https://doi.org/10.1007/s10354-023-01018-4.
  • Peball M, Heim B, Carbone F, et al. Long-term safety and efficacy of open-label nabilone on sleep and pain in Parkinson s Disease. NPJ Parkinsons Dis 2024;10:61. https://doi.org/10.1038/s41531-024-00665-7.
  • Rakusa M, Moro E, Akhvlediani T, et al. The COVID-19 pandemic and neurology: A survey on previous and continued restrictions for clinical practice, curricular training, and health economics. Eur J Neurol 2024;31:e16168. https://doi.org/10.1111/ene.16168.
  • Sidoroff V, Carbone F, Ellmerer P, et al. Emotion Recognition in Multiple System Atrophy: An Exploratory Eye-Tracking Study. J Mov Disord 2024;17:38-46. https://doi.org/10.14802/jmd.23090.
  • Theyer C, Beliveau V, Krismer F, et al. Long-Term Medication Profiles in Parkinson's Disease under Subthalamic Deep Brain Stimulation: A Controlled Study. Mov Disord Clin Pract 2024. https://doi.org/10.1002/mdc3.14065.
  • Waiss C, Strobele B, Graichen U, et al. CXCL13 as a biomarker in the diagnostics of European lyme Neuroborreliosis - A prospective multicentre study in Austria. J Cent Nerv Syst Dis 2024;16:11795735241247026. https://doi.org/10.1177/11795735241247026.
  • Wasay M, Grisold W, Wijeratne T, Struhal W, Younis S, World Federation of N. The future of brain health advocacy: Recommendations of the 2023 World Congress of Neurology advocacy panel. J Neurol Sci 2024;458:122914. https://doi.org/10.1016/j.jns.2024.122914.

2023

  • Brignole M, Aksu T, Calo L, et al. Clinical controversy: methodology and indications of cardioneuroablation for reflex syncope. Europace 2023;25. https://doi.org/10.1093/europace/euad033.
  • Burnyasheva AO, Stefanova NA, Kolosova NG, Telegina DV. Changes in the Glutamate/GABA System in the Hippocampus of Rats with Age and during Alzheimer's Disease Signs Development. Biochemistry (Mosc) 2023;88:1972-1986. https://doi.org/10.1134/S0006297923120027.
  • Calio B, Wenning GK, Fanciulli A, Colosimo C. Forehead and scalp gustatory sweating after temporomandibular joint surgery: an atypical presentation of Frey's syndrome. Clin Auton Res 2023;33:201-203. https://doi.org/10.1007/s10286-023-00931-3.
  • Campese N, Calio B, Leys F, et al. Pain in Multiple System Atrophy a Systematic Review and Meta-Analysis. Mov Disord Clin Pract 2023;10:1738-1749. doi.org/10.1002/mdc3.13897.
  • Chadaeva IV, Filonov SV, Zolotareva KA, et al. RatDEGdb: a knowledge base of differentially expressed genes in the rat as a model object in biomedical research. Vavilovskii Zhurnal Genet Selektsii 2023;27:794-806. https://doi.org/10.18699/VJGB-23-92.
  • Cheng A, Jia W, Finkelstein DI, et al. Pharmacological inhibition of FABP7 by MF 6 counteracts cerebellum dysfunction in an experimental multiple system atrophy mouse model. Acta Pharmacol Sin 2024;45:66-75. https://doi.org/10.1038/s41401-023-01138-y.
  • Cheng A, Kawahata I, Wang Y, et al. Epsin2, a novel target for multiple system atrophy therapy via alpha-synuclein/FABP7 propagation. Brain 2023;146:3172-3180. https://doi.org/10.1093/brain/awad137.
  • Dutta S, Hornung S, Taha HB, et al. Development of a Novel Electrochemiluminescence ELISA for Quantification of alpha-Synuclein Phosphorylated at Ser(129) in Biological Samples. ACS Chem Neurosci 2023;14:1238-1248. https://doi.org/10.1021/acschemneuro.2c00676.
  • Eckhardt C, Fanciulli A, Hogl B, et al. Analysis of sleep, daytime sleepiness, and autonomic function in multiple system atrophy and Parkinson disease: a prospective study. J Clin Sleep Med 2023;19:63-71. https://doi.org/10.5664/jcsm.10268.
  • Eschlboeck S, Goebel G, Eckhardt C, et al. Development and Validation of a Prognostic Model to Predict Overall Survival in Multiple System Atrophy. Mov Disord Clin Pract 2023;10:1368-1376. https://doi.org/10.1002/mdc3.13822.
  • Fanciulli A, Leys F, Krbot Skoric M, et al. Impact of the COVID-19 pandemic on clinical autonomic practice in Europe A survey of the European Academy of Neurology (EAN) and the European Federation of Autonomic Societies (EFAS). Eur J Neurol 2023. https://doi.org/10.1111/ene.15787.
  • Fanciulli A, Skoric MK, Leys F, et al. EFAS/EAN survey on the influence of the COVID-19 pandemic on European clinical autonomic education and research. Clin Auton Res 2023;33:777-790. https://doi.org/10.1007/s10286-023-00985-3.
  • Grossauer A, Hemicker G, Krismer F, et al. alpha-Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid-A Systematic Review and Meta-Analysis. Mov Disord Clin Pract 2023;10:737-747. https://doi.org/10.1002/mdc3.13710.
  • Grossauer A, Muller C, Hussl A, et al. Dorsolateral Nigral Hyperintensity on 1.5 T Versus 3 T Susceptibility-Weighted Magnetic Resonance Imaging in Neurodegenerative Parkinsonism. Mov Disord Clin Pract 2023;10:914-921. https://doi.org/10.1002/mdc3.13736.
  • Heim B, Peball M, Krismer F, Djamshidian A, Seppi K. Pimavanserin: A Truly Effective Treatment for Parkinson's Disease Psychosis? A Review of Interventions. Neuropsychiatr Dis Treat 2023;19:1303-1312. https://doi.org/10.2147/NDT.S371641.
  • Hristozov K, Dimitrova R, Shishkov S, Stefanova N, Gercheva S. Primary Intrathyroidal Non-Hodgkin Lymphoma: A Case Report. Cureus 2023;15:e47096. https://doi.org/10.7759/cureus.47096.
  • Krismer F, Peran P, Beliveau V, et al. Progressive Brain Atrophy in Multiple System Atrophy: A Longitudinal, Multicenter, Magnetic Resonance Imaging Study. Mov Disord 2024;39:119-129. https://doi.org/10.1002/mds.29633.
  • Ludwig B, Olbert E, Trimmel K, et al. [The overview on current evidence for the treatment of ME/CFS is based on the principles of scientific assessment]. Nervenarzt 2023;94:738-740. https://doi.org/10.1007/s00115-023-01516-1.
  • Molobekova CA, Kondaurova EM, Ilchibaeva TV, et al. Amisulpride Decreases Tau Protein Hyperphosphorylation in the Brain of OXYS Rats. Curr Alzheimer Res 2023;20:496-505. https://doi.org/10.2174/1567205020666230828144651.
  • Olbert E, Alhani N, Struhal W. Retrospective analysis of COVID-19 patients with Guillain-Barre, Miller-Fisher, and opsoclonus-myoclonus-ataxia syndromes-a case series. Wien Med Wochenschr 2024;174:30-34. https://doi.org/10.1007/s10354-023-01018-4.
  • Ortner NJ, Sah A, Paradiso E, et al. The human channel gating-modifying A749G CACNA1D (Cav1.3) variant induces a neurodevelopmental syndrome-like phenotype in mice. JCI Insight 2023;8. https://doi.org/10.1172/jci.insight.162100.
  • Peball M, Valent D, Grossauer A, et al. Temporal Muscle Thickness Correlates with Sarcopenia in Parkinson's Disease. J Parkinsons Dis 2023;13:341-350. https://doi.org/10.3233/JPD-225108.
  • Rabady S, Hoffmann K, Aigner M, et al. [S1 guidelines for the management of postviral conditions using the example of post-COVID-19]. Wien Klin Wochenschr 2023;135:525-598. https://doi.org/10.1007/s00508-023-02242-z.
  • Raket LL, Hansen IH, Kuhnel L, et al. Reply to Letter to the Editor: "Disease Progression in Multiple System Atrophy: The Value of Clinical Cohorts with Long Follow-Up". Mov Disord 2023;38:1569-1570. https://doi.org/10.1002/mds.29535.
  • Rakusa M, Moro E, Akhvlediani T, et al. The COVID-19 pandemic and neurology: A survey on previous and continued restrictions for clinical practice, curricular training, and health economics. Eur J Neurol 2024;31:e16168. https://doi.org/10.1111/ene.16168.
  • Reis Carneiro D, Rocha I, Habek M, et al. Clinical presentation and management strategies of cardiovascular autonomic dysfunction following a COVID-19 infection - A systematic review. Eur J Neurol 2023;30:1528-1539. https://doi.org/10.1111/ene.15714.
  • Rinaldi D, Galli S, Fanciulli A, Pontieri FE. Levodopa/carbidopa intestinal gel via percutaneous endoscopic transgastric jejunostomy in advanced Parkinson's disease: hitting two birds with one stone? Parkinsonism Relat Disord 2023;112:105394. https://doi.org/10.1016/j.parkreldis.2023.105394.
  • Rudnitskaya E, Kozlova T, Burnyasheva A, et al. Postnatal Maturation of the Blood-Brain Barrier in Senescence-Accelerated OXYS Rats, Which Are Prone to an Alzheimer's Disease-like Pathology. Int J Mol Sci 2023;24. https://doi.org/10.3390/ijms242115649.
  • Sidoroff V, Carbone F, Ellmerer P, et al. Emotion Recognition in Multiple System Atrophy: An Exploratory Eye-Tracking Study. J Mov Disord 2024;17:38-46. https://doi.org/10.14802/jmd.23090.
  • Stankovic I, Fanciulli A, Sidoroff V, Wenning GK. A Review on the Clinical Diagnosis of Multiple System Atrophy. Cerebellum 2023;22:825-839. https://doi.org/10.1007/s12311-022-01453-w.
  • Stefani A, Trenkwalder C, Arnulf I, et al. Isolated rapid eye movement sleep behaviour disorder: clinical and research implications. J Neurol Neurosurg Psychiatry 2023;94:581-582. https://doi.org/10.1136/jnnp-2022-330913.
  • Stefanova N. A Mouse Model of Multiple System Atrophy: Bench to Bedside. Neurotherapeutics 2023;20:117-126. https://doi.org/10.1007/s13311-022-01287-8.
  • Stefanova N, Kalinov T, Kolev N, Kalchev E. Frantz Tumor: A Case Report of Solid Pseudopapillary Tumor of Pancreas. Cureus 2023;15:e41698. https://doi.org/10.7759/cureus.41698.
  • Stefanova N, Wenning GK. Multiple system atrophy: at the crossroads of cellular, molecular and genetic mechanisms. Nat Rev Neurosci 2023;24:334-346. https://doi.org/10.1038/s41583-023-00697-7.
  • Stefanova NA, Kolosova NG. The Rat Brain Transcriptome: From Infancy to Aging and Sporadic Alzheimer's Disease-like Pathology. Int J Mol Sci 2023;24. https://doi.org/10.3390/ijms24021462.
  • Torre-Muruzabal T, Van der Perren A, Coens A, et al. Host oligodendrogliopathy and alpha-synuclein strains dictate disease severity in multiple system atrophy. Brain 2023;146:237-251. https://doi.org/10.1093/brain/awac061.
  • Valent D, Krismer F, Grossauer A, et al. Nomogram to Predict the Probability of Functional Dependence in Early Parkinson's Disease. J Parkinsons Dis 2023;13:49-55. https://doi.org/10.3233/JPD-223501.
  • Vignatelli L, Calandra-Buonaura G, Stankovic I, Kaufmann H, Cortelli P, Wenning GK. The Framework for Diagnostic Criteria in Movement Disorders: The Value of Methodological Tools and Combined Criteria. Mov Disord 2023;38:1762-1763. https://doi.org/10.1002/mds.29587.

2022

  • Brunner C, Schreiber SJ, Bokemeyer M, et al. Value of ultrasound fusion imaging in detecting vascular cerebral white matter pathology. Ultrasound J 2022;14:25. https://doi.org/10.1186/s13089-022-00275-5.
  • Campese N, Fanciulli A. Look broader, see closer: A glimpse into the pre-diagnostic stage of multiple system atrophy. Parkinsonism Relat Disord 2022;99:105-106.  https://doi.org/10.1016/j.parkreldis.2022.06.005.
  • Campese N, Leys F, Wenning GK, Fanciulli A. Bedside Assessment of Autonomic Dysfunction in Multiple System Atrophy. J Parkinsons Dis 2022;12:2277-2281. https://doi.org/10.3233/JPD-223357.
  • Dimaras P, Tasinov O, Ivanova D, et al. Improving gene expression analysis efficacy from formalin-fixed paraffin embedded tissues. Folia Med (Plovdiv) 2022;64:602-608. https://doi.org/10.3897/folmed.64.e63599.
  • Eckhardt C, Krismer F, Donnemiller E, et al. Cardiac sympathetic innervation in Parkinson's disease versus multiple system atrophy. Clin Auton Res 2022;32:103-114. https://doi.org/10.1007/s10286-022-00853-6.
  • Ellmerer P, Peball M, Carbone F, et al. Eye Tracking in Patients with Parkinson's Disease Treated with Nabilone-Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot Study. Brain Sci 2022;12. https://doi.org/10.3390/brainsci12050661.
  • Fanciulli A, Leys F, Lehner F, et al. A multiplex pedigree with pathologically confirmed multiple system atrophy and Parkinson's disease with dementia. Brain Commun 2022;4:fcac175. https://doi.org/10.1093/braincomms/fcac175.
  • Finkelstein DI, Shukla JJ, Cherny RA, et al. The Compound ATH434 Prevents Alpha-Synuclein Toxicity in a Murine Model of Multiple System Atrophy. J Parkinsons Dis 2022;12:105-115. https://doi.org/10.3233/JPD-212877.
  • Habek M, Andabaka M, Fanciulli A, et al. Sudomotor dysfunction in people with neuromyelitis optica spectrum disorders. Eur J Neurol 2022;29:2772-2780. https://doi.org/10.1111/ene.15413.
  • Habek M, Leys F, Krbot Skoric M, et al. Clinical autonomic nervous system laboratories in Europe: A joint survey of the European Academy of Neurology and the European Federation of Autonomic Societies: A joint survey of the European Academy of Neurology and the European Federation of Autonomic Societies. Eur J Neurol 2022;29:3633-3646. https://doi.org/10.1111/ene.15538.
  • Heim B, Peball M, Hammermeister J, Djamshidian A, Krismer F, Seppi K. Differentiating Parkinson's Disease from Essential Tremor Using Transcranial Sonography: A Systematic Review and Meta-Analysis. J Parkinsons Dis 2022;12:1115-1123. https://doi.org/10.3233/JPD-213012.
  • Jucaite A, Cselenyi Z, Kreisl WC, et al. Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [(11) C]PBR28 and Machine Learning Analysis. Mov Disord 2022;37:119-129. https://doi.org/10.1002/mds.28814.
  • Kolosova NG, Kozhevnikova OS, Muraleva NA, et al. SkQ1 as a Tool for Controlling Accelerated Senescence Program: Experiments with OXYS Rats. Biochemistry (Mosc) 2022;87:1552-1562. https://doi.org/10.1134/S0006297922120124.
  • Kozlova T, Rudnitskaya E, Burnyasheva A, Stefanova N, Peunov D, Kolosova N. Delayed Formation of Neonatal Reflexes and of Locomotor Skills Is Associated with Poor Maternal Behavior in OXYS Rats Prone to Alzheimer's Disease-like Pathology. Biomedicines 2022;10. https://doi.org/10.3390/biomedicines10112910.
  • Krismer F, Palma JA, Calandra-Buonaura G, et al. The Unified Multiple System Atrophy Rating Scale: Status, Critique, and Recommendations. Mov Disord 2022;37:2336-2341. https://doi.org/10.1002/mds.29215.
  • Krismer F, Seppi K, Jonsson L, et al. Sensitivity to Change and Patient-Centricity of the Unified Multiple System Atrophy Rating Scale Items: A Data-Driven Analysis. Mov Disord 2022;37:1425-1431. https://doi.org/10.1002/mds.28993.
  • Kuhnel L, Raket LL, Astrom DO, et al. Disease Progression in Multiple System Atrophy-Novel Modeling Framework and Predictive Factors. Mov Disord 2022;37:1719-1727. doi.org/10.1002/mds.29077.
  • Leys F, Eschlbock S, Campese N, et al. Family History for Neurodegeneration in Multiple System Atrophy: Does it Indicate Susceptibility? Mov Disord 2022;37:2310-2312. https://doi.org/10.1002/mds.29202.
  • Leys F, Fanciulli A. The extended role of 24 h ambulatory blood pressure monitoring for reflex syncope. Eur Heart J 2022;43:3777-3780. https://doi.org/10.1093/eurheartj/ehac409.
  • Leys F, Wenning GK, Fanciulli A. The role of cardiovascular autonomic failure in the differential diagnosis of alpha-synucleinopathies. Neurol Sci 2022;43:187-198. https://doi.org/10.1007/s10072-021-05746-6.
  • Ndayisaba A, Pitaro AT, Willett AS, et al. Correction to: Clinical trial-ready patient cohorts for multiple system atrophy: coupling biospecimen and iPSC banking to longitudinal deep-phenotyping. Cerebellum 2022. https://doi.org/10.1007/s12311-022-01501-5.
  • Ndayisaba A, Pitaro AT, Willett AS, et al. Clinical Trial-Ready Patient Cohorts for Multiple System Atrophy: Coupling Biospecimen and iPSC Banking to Longitudinal Deep-Phenotyping. Cerebellum 2022:1-21. https://doi.org/10.1007/s12311-022-01471-8.
  • Olbert E, Brunner C, Alhani N, Nasel C, Struhal W. MOG antibody associated disease (MOGAD) presenting with extensive brain stem encephalitis: A case report. eNeurologicalSci 2022;29:100432. https://doi.org/10.1016/j.ensci.2022.100432.
  • Olbert E, Struhal W. Retinal imaging with optical coherence tomography in multiple sclerosis: novel aspects. Wien Med Wochenschr 2022;172:329-336. https://doi.org/10.1007/s10354-022-00925-2.
  • Palma JA, Krismer F, Meissner WG, et al. Patient-Reported Symptoms in the Global Multiple System Atrophy Registry. Mov Disord Clin Pract 2022;9:967-971. https://doi.org/10.1002/mdc3.13544.
  • Peball M, Seppi K, Krismer F, et al. Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post-hoc Analysis of NMS-Nab Study. Mov Disord Clin Pract 2022;9:751-758. https://doi.org/10.1002/mdc3.13471.
  • Poewe W, Stankovic I, Halliday G, et al. Multiple system atrophy. Nat Rev Dis Primers 2022;8:56. https://doi.org/10.1038/s41572-022-00382-6.
  • Quattrone A, Bianco MG, Antonini A, et al. Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease. Mov Disord 2022;37:1272-1281. https://doi.org/10.1002/mds.28992.
  • Rudnitskaya EA, Burnyasheva AO, Kozlova TA, Peunov DA, Kolosova NG, Stefanova NA. Changes in Glial Support of the Hippocampus during the Development of an Alzheimer's Disease-like Pathology and Their Correction by Mitochondria-Targeted Antioxidant SkQ1. Int J Mol Sci 2022;23. https://doi.org/10.3390/ijms23031134.
  • Sidoroff V, Bower P, Stefanova N, et al. Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022? J Parkinsons Dis 2022;12:1369-1387. https://doi.org/10.3233/JPD-223183.
  • Stankovic I, Fanciulli A, Sidoroff V, Wenning GK. A Review on the Clinical Diagnosis of Multiple System Atrophy. Cerebellum 2022. https://doi.org/10.1007/s12311-022-01453-w.
  • Stefanova N, Enchev Y, Dzhenkov D, Hachmeryan A. Paraganglioma in the spinal cord histologically mimicking ependymoma - a case report. Folia Med (Plovdiv) 2022;64:1007-1011. https://doi.org/10.3897/folmed.64.e71407.
  • Ucar B, Stefanova N, Humpel C. Spreading of Aggregated alpha-Synuclein in Sagittal Organotypic Mouse Brain Slices. Biomolecules 2022;12. https://doi.org/10.3390/biom12020163.
  • Valent D, Peball M, Krismer F, et al. Different assessment tools to detect sarcopenia in patients with Parkinson's disease. Front Neurol 2022;13:1014102. https://doi.org/10.3389/fneur.2022.1014102.
  • Wenning GK, Bower P. Bishop Dr. Karl Golser Prize 2022 awarded to Prof. Wolfgang Singer. Clin Auton Res 2022;32:227-228. https://doi.org/10.1007/s10286-022-00875-0.
  • Wenning GK, Stankovic I, Vignatelli L, et al. The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy. Mov Disord 2022;37:1131-1148. https://doi.org/10.1002/mds.29005.
  • Wenning GK, Stankovic I, Vignatelli L, et al. The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy. Mov Disord 2022;37:1131-1148. https://doi.org/10.1002/mds.29005.

2021

  • Beliveau V, Krismer F, Skalla E, et al. Characterization and diagnostic potential of diffusion tractography in multiple system atrophy. Parkinsonism Relat Disord 2021;85:30-36. https://doi.org/10.1016/j.parkreldis.2021.02.027.
  • Calandra-Buonaura G, Alfonsi E, Vignatelli L, et al. Dysphagia in multiple system atrophy consensus statement on diagnosis, prognosis and treatment. Parkinsonism Relat Disord 2021;86:124-132. https://doi.org/10.1016/j.parkreldis.2021.03.027.
  • Campese N, Fanciulli A, Stefanova N, Haybaeck J, Kiechl S, Wenning GK. Neuropathology of multiple system atrophy: Kurt Jellinger`s legacy. J Neural Transm (Vienna) 2021;128:1481-1494. https://doi.org/10.1007/s00702-021-02383-3
  • Campese N, Fanciulli A, Stefanova N, Haybaeck J, Kiechl S, Wenning GK. Correction to: Neuropathology of multiple system atrophy: Kurt Jellinger`s legacy. J Neural Transm (Vienna) 2021;128:1495. https://doi.org/10.1007/s00702-021-02412-1
  • Campese N, Goebel G, Leys F, et al. Orthostatic Hypotension in Parkinson's Disease: Do Height and Weight Matter? Mov Disord 2021;36:2703-2705. https://doi.org/10.1002/mds.28768.
  • Cheshire WP, Freeman R, Gibbons CH, et al. Electrodiagnostic assessment of the autonomic nervous system: A consensus statement endorsed by the American Autonomic Society, American Academy of Neurology, and the International Federation of Clinical Neurophysiology. Clin Neurophysiol 2021;132:666-682. https://doi.org/10.1016/j.clinph.2020.11.024.
  • Cheshire WP, Freeman R, Gibbons CH, et al. Corrigendum to "Electrodiagnostic assessment of the autonomic nervous system: A consensus statement endorsed by the American Autonomic Society, American Academy of Neurology, and the International Federation of Clinical Neurophysiology" [Clin. Neurophysiol. 132(2) (2021) 666-682]. Clin Neurophysiol 2021;132:1194. https://doi.org/10.1016/j.clinph.2021.02.006.
  • Dumic K, Krnic N, Jovanovic I, et al. Insular damage causing transient baroreflex dysfunction in a teenager with Allgrove syndrome. Clin Auton Res 2021;31:581-584. https://doi.org/10.1007/s10286-021-00779-5.
  • Eschlbock S, Kiss G, Krismer F, et al. Urodynamic Evaluation in Multiple System Atrophy: A Retrospective Cohort Study. Mov Disord Clin Pract 2021;8:1052-1060. https://doi.org/10.1002/mdc3.13307.
  • Fanciulli A, Wenning GK. Autonomic failure: a neglected presentation of Parkinson's disease. Lancet Neurol 2021;20:781-782. https://doi.org/10.1016/S1474-4422(21)00292-1.
  • Geser F, Jellinger KA, Fellner L, Wenning GK, Yilmazer-Hanke D, Haybaeck J. Emergent creativity in frontotemporal dementia. J Neural Transm (Vienna) 2021;128:279-293. https://doi.org/10.1007/s00702-021-02325-z.
  • Grotsch MT, Respondek G, Colosimo C, et al. A Modified Progressive Supranuclear Palsy Rating Scale. Mov Disord 2021;36:1203-1215. https://doi.org/10.1002/mds.28470.
  • Heim B, Krismer F, Seppi K. Differentiating PSP from MSA using MR planimetric measurements: a systematic review and meta-analysis. J Neural Transm (Vienna) 2021;128:1497-1505. https://doi.org/10.1007/s00702-021-02362-8.
  • Heim B, Mangesius S, Krismer F, et al. Diagnostic accuracy of MR planimetry in clinically unclassifiable parkinsonism. Parkinsonism Relat Disord 2021;82:87-91. doi.org/10.1016/j.parkreldis.2020.11.019.
  • Heras-Garvin A, Refolo V, Schmidt C, et al. ATH434 Reduces alpha-Synuclein-Related Neurodegeneration in a Murine Model of Multiple System Atrophy. Mov Disord 2021;36:2605-2614. https://doi.org/10.1002/mds.28714.
  • Herrera-Vaquero M, Heras-Garvin A, Krismer F, et al. Signs of early cellular dysfunction in multiple system atrophy. Neuropathol Appl Neurobiol 2021;47:268-282. doi.org/10.1111/nan.12661.
  • Jellinger KA, Wenning GK, Stefanova N. Is Multiple System Atrophy a Prion-like Disorder? Int J Mol Sci 2021;22. https://doi.org/10.3390/ijms221810093.
  • Krismer F, Beliveau V, Seppi K, et al. Automated Analysis of Diffusion-Weighted Magnetic Resonance Imaging for the Differential Diagnosis of Multiple System Atrophy from Parkinson's Disease. Mov Disord 2021;36:241-245. https://doi.org/10.1002/mds.28281.
  • Krismer F, Seppi K. The Parkinson disease connectome - insights from new imaging studies. Nat Rev Neurol 2021;17:527-528. https://doi.org/10.1038/s41582-021-00543-3.
  • Lemos M, Wenning GK, Stefanova N. Current experimental disease-modifying therapeutics for multiple system atrophy. J Neural Transm (Vienna) 2021;128:1529-1543.  https://doi.org/10.1007/s00702-021-02406-z.
  • Palma JA, Vernetti PM, Perez MA, et al. Limitations of the Unified Multiple System Atrophy Rating Scale as outcome measure for clinical trials and a roadmap for improvement. Clin Auton Res 2021;31:157-164. https://doi.org/10.1007/s10286-021-00782-w.
  • Quattrone A, Antonini A, Vaillancourt DE, et al. A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson's Disease in Clinical Practice: An International Study. Mov Disord 2021;36:681-689. https://doi.org/10.1002/mds.28364
  • Raccagni C, Indelicato E, Sidoroff V, et al. Female sexual dysfunction in multiple system atrophy: a prospective cohort study. Clin Auton Res 2021;31:713-717. https://doi.org/10.1007/s10286-021-00825-2.
  • Shadrin AA, Mucha S, Ellinghaus D, et al. Shared Genetics of Multiple System Atrophy and Inflammatory Bowel Disease. Mov Disord 2021;36:449-459. https://doi.org/10.1002/mds.28338.
  • Sidoroff V, Raccagni C, Kaindlstorfer C, et al. Characterization of gait variability in multiple system atrophy and Parkinson's disease. J Neurol 2021;268:1770-1779. https://doi.org/10.1007/s00415-020-10355-y.
  • Stankovic I, Fanciulli A, Kostic VS, et al. Laboratory-Supported Multiple System Atrophy beyond Autonomic Function Testing and Imaging: A Systematic Review by the MoDiMSA Study Group. Mov Disord Clin Pract 2021;8:322-340. https://doi.org/10.1002/mdc3.13158.
  • Taylor CE, Arnold AC, Fanciulli A, et al. Women in clinical autonomic research and the autonomic societies: how far have we come in thirty years? Clin Auton Res 2021;31:23-26. https://doi.org/10.1007/s10286-021-00768-8.
  • Thijs RD, Brignole M, Falup-Pecurariu C, et al. Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness : Consensus statement of the European Federation of Autonomic Societies (EFAS) endorsed by the American Autonomic Society (AAS) and the European Academy of Neurology (EAN). Auton Neurosci 2021;233:102792. https://doi.org/10.1016/j.autneu.2021.102792.
  • van Dijk JG, Benditt DG, Fanciulli A, et al. Toward a Common Definition of Syncope in Children and Adults. Pediatr Emerg Care 2021;37:e66-e67. https://doi.org/10.1097/PEC.0000000000002309.
  • Venezia S, Kaufmann WA, Wenning GK, Stefanova N. Toll-like receptor 4 deficiency facilitates alpha-synuclein propagation and neurodegeneration in a mouse model of prodromal Parkinson's disease. Parkinsonism Relat Disord 2021;91:59-65. https://doi.org/10.1016/j.parkreldis.2021.09.007.
  • Wenning GK, Riederer P. Kurt Jellinger, Doyen of international neuropathology. J Neural Transm (Vienna) 2021;128:1479-1480. https://doi.org/10.1007/s00702-021-02397-x.

2020

  • Eschlböck S, Delazer M, Krismer F, et al. Cognition in multiple system atrophy: a single-center cohort study. Ann Clin Transl Neurol 2020;7:219-228. doi.org/10.1002/acn3.50987.
  • Fanciulli A, Campese N, Goebel G, et al. Association of transient orthostatic hypotension with falls and syncope in patients with Parkinson disease. Neurology 2020;95:e2854-e2865. doi.org/10.1212/wnl.0000000000010749.
  • Fanciulli A, Kerer K, Leys F, et al. Validation of the Neurogenic Orthostatic Hypotension Ratio with Active Standing. Annals of neurology 2020;88:643-645. doi.org/10.1002/ana.25834.
  • Fanciulli A, Leys F, Falup-Pecurariu C, Thijs R, Wenning GK. Management of Orthostatic Hypotension in Parkinson's Disease. Journal of Parkinson's disease 2020;10:S57-s64. doi.org/10.3233/jpd-202036.
  • Fanciulli A, Wenning GK. Which Autonomic Features Distinguish Multiple System Atrophy and When. Movement disorders : official journal of the Movement Disorder Society 2020;35:902-903. doi.org/10.1002/mds.28050.
  • Fellner L, Jellinger KA, Wenning GK, Haybaeck J. Commentary: Discriminating α-synuclein strains in parkinson's disease and multiple system atrophy. Frontiers in neuroscience 2020;14:802. doi.org/10.3389/fnins.2020.00802.
  • Findling O, Hauer L, Pezawas T, Rommer PS, Struhal W, Sellner J. Cardiac Autonomic Dysfunction in Multiple Sclerosis: A Systematic Review of Current Knowledge and Impact of Immunotherapies. Journal of clinical medicine 2020;9. doi.org/10.3390/jcm9020335.
  • Heras-Garvin A, Danninger C, Eschlböck S, Holton JL, Wenning GK, Stefanova N. Signs of Chronic Hypoxia Suggest a Novel Pathophysiological Event in α-Synucleinopathies. Movement disorders : official journal of the Movement Disorder Society 2020. doi.org/10.1002/mds.28229.
  • Herrera-Vaquero M, Heras-Garvin A, Krismer F, et al. Signs of early cellular dysfunction in multiple system atrophy. Neuropathology and applied neurobiology 2020. doi.org/10.1111/nan.12661.
  • Indelicato E, Fanciulli A, Nachbauer W, et al. Cardiovascular autonomic testing in the work-up of cerebellar ataxia: insight from an observational single center study. Journal of neurology 2020;267:1097-1102. doi.org/10.1007/s00415-019-09684-4.
  • Krismer F, Beliveau V, Seppi K, et al. Automated Analysis of Diffusion-Weighted Magnetic Resonance Imaging for the Differential Diagnosis of Multiple System Atrophy from Parkinson's Disease. Movement disorders : official journal of the Movement Disorder Society 2020. doi.org/10.1002/mds.28281.
  • Leys F, Fanciulli A, Ndayisaba JP, Granata R, Struhal W, Wenning GK. Cardiovascular autonomic function testing in multiple system atrophy and Parkinson's disease: an expert-based blinded evaluation. Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2020;30:255-263. doi.org/10.1007/s10286-020-00691-4.
  • Leys F, Raccagni C, Sidoroff V, Seppi K, Fanciulli A, Wenning GK. Effects of self-administered cannabidiol in a patient with multiple system atrophy. Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2020;30:355-356. doi.org/10.1007/s10286-020-00704-2.
  • Mitterer W, Lanser L, Fodor M, Weiss J, Scholz SW, Wenning GK. Conjugal multiple system atrophy: Rethinking numbers of probability. Parkinsonism & related disorders 2020;77:176-177. doi.org/10.1016/j.parkreldis.2020.08.005.
  • Pellecchia MT, Stankovic I, Fanciulli A, et al. Can Autonomic Testing and Imaging Contribute to the Early Diagnosis of Multiple System Atrophy? A Systematic Review and Recommendations by the Movement Disorder Society Multiple System Atrophy Study Group. Movement disorders clinical practice 2020;7:750-762. doi.org/10.1002/mdc3.13052.
  • Raccagni C, Sidoroff V, Goebel G, et al. The footprint of orthostatic hypotension in parkinsonian syndromes. Parkinsonism & related disorders 2020;77:107-109. doi.org/10.1016/j.parkreldis.2020.06.029.
  • Wenning GK. Parkinsonism and dysautonomia: Multiple system atrophy? Parkinsonism & related disorders 2020;77:150-151. doi.org/10.1016/j.parkreldis.2019.08.006.
  • Zunke P, Auffarth A, Hitzl W, Moursy M. The effect of manual therapy to the thoracic spine on pain-free grip and sympathetic activity in patients with lateral epicondylalgia humeri. A randomized, sample sized planned, placebo-controlled, patient-blinded monocentric trial. BMC Musculoskelet Disord 2020;21:186. doi.org/10.1186/s12891-020-3175-y.

 

2019

  • Fanciulli A, Goebel G, Lazzeri G, et al. Urinary retention discriminates multiple system atrophy from Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society 2019;34:1926-1928. doi.org/10.1002/mds.27917.
  • Fanciulli A, Stankovic I, Krismer F, et al. Multiple system atrophy. International review of neurobiology 2019;149:137-192. doi.org/10.1016/bs.irn.2019.10.004.
  • Indelicato E, Fanciulli A, Nachbauer W, et al. Cardiovascular autonomic testing in the work-up of cerebellar ataxia: insight from an observational single center study. Journal of neurology 2019. doi.org/10.1007/s00415-019-09684-4.
  • Raccagni C, Goebel G, Gassner H, et al. Physiotherapy improves motor function in patients with the Parkinson variant of multiple system atrophy: A prospective trial. Parkinsonism & related disorders 2019;67:60-65. doi.org/10.1016/j.parkreldis.2019.09.026.
  • Fanciulli A, Campese N, Wenning GK. The Schellong test: detecting orthostatic blood pressure and heart rate changes in German-speaking countries. Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2019;29:363-366. doi.org/10.1007/s10286-019-00619-7.
  • Jordan J, Fanciulli A, Tank J, et al. Management of supine hypertension in patients with neurogenic orthostatic hypotension: scientific statement of the American Autonomic Society, European Federation of Autonomic Societies, and the European Society of Hypertension. Journal of hypertension 2019;37:1541-1546. doi.org/10.1097/hjh.0000000000002078.
  • Ndayisaba A, Herrera-Vaquero M, Wenning GK, et al. Induced pluripotent stem cells in multiple system atrophy: recent developments and scientific challenges. Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2019;29:385-395. doi.org/10.1007/s10286-019-00614-y.
  •  Stankovic I, Quinn N, Vignatelli L, et al. A critique of the second consensus criteria for multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society 2019;34:975-984. doi.org/10.1002/mds.27701.
  • Fanciulli A, Goebel G, Lazzeri G, et al. Early distinction of Parkinson-variant multiple system atrophy from Parkinson's disease. Mov Disord 2019;34:440-441. doi.org/10.1002/mds.27635.
  •  Jordan J, Fanciulli A, Tank J, et al. Management of supine hypertension in patients with neurogenic orthostatic hypotension: scientific statement of the American Autonomic Society, European Federation of Autonomic Societies, and the European Society of Hypertension. Journal of hypertension 2019. doi.org/10.1097/hjh.0000000000002078.

2018

  • Brignole M, Moya A, de Lange FJ, et al. [2018 ESC Guidelines for the diagnosis and management of syncope]. Kardiologia polska 2018;76:1119-1198. doi.org/10.5603/kp.2018.0161.
  • Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J 2018;39:1883-1948. doi.org/10.1093/eurheartj/ehy037.
  • Brignole M, Moya A, de Lange FJ, et al. Practical Instructions for the 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J 2018;39:e43-e80. doi.org/10.1093/eurheartj/ehy071.
  • Eschlbock S, Wenning G, Fanciulli A. Correction to: Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms. J Neural Transm (Vienna) 2018;125:273-274. doi.org/10.1007/s00702-017-1814-8.
  • Eschlboeck S, Krismer F, Wenning GK. Key themes and future prospects in translational multiple system atrophy research. Auton Neurosci 2018;211:43-45. doi.org/10.1016/j.autneu.2017.08.004.
  • Fanciulli A, Jordan J, Biaggioni I, et al. Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS) : Endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH). Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2018;28:355-362. doi.org/10.1007/s10286-018-0529-8.
  • Indelicato E, Fanciulli A, Ndayisaba JP, et al. Autonomic function testing in Friedreich's ataxia. J Neurol 2018;265:2015-2022. doi.org/10.1007/s00415-018-8946-0.
  • Indelicato E, Fanciulli A, Ndayisaba JP, et al. Autonomic function testing in spinocerebellar ataxia type 2. Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2018;28:341-346. doi.org/10.1007/s10286-018-0504-4.
  • Pargfrieder C, Struhal W, Sega W, et al. Acquired idiopathic generalized anhidrosis in a young Austrian patient. JAAD case reports 2018;4:222-225. doi.org/10.1016/j.jdcr.2017.09.012.
  • Pavy-Le Traon A, Cotterill N, Amarenco G, et al. Clinical Rating Scales for Urinary Symptoms in Parkinson Disease: Critique and Recommendations. Mov Disord Clin Pract 2018;5:479-491. doi.org/10.1002/mdc3.12636.
  • Struhal W, Thijs RD, Pavy-Le Traon A, et al. In memoriam: Sir Roger Bannister 1929-2018. Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2018;28:351. doi.org/10.1007/s10286-018-0535-x.

2017

  • Eschlbock S, Wenning G, Fanciulli A. Correction to: Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms. J Neural Transm (Vienna) 2017. https://doi.org/10.1007/s00702-017-1814-8.
  • Eschlbock S, Wenning G, Fanciulli A. Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms. J Neural Transm (Vienna) 2017;124:1567-1605. https://doi.org/10.1007/s00702-017-1791-y.

2016

  • Pavy-Le Traon A, Piedvache A, Perez-Lloret S et.al. New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study. Journal of neurology, neurosurgery, and psychiatry 2016;87:554-561. doi.org/10.1136/jnnp-2014-309999.
  • Ndayisaba JP, Fanciulli A, Granata R et.al. Erratum to: Sex and age effects on cardiovascular autonomic function in healthy adults. Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2016;26:169-170. doi.org/10.1007/s10286-015-0335-5.
  • Corazza I, Struhal W, Mahringer C et.al. From Autonomic Nervous System Evaluation to a Novel Paradigm for Scientific Research, Clinical Practice and Economic Development. Journal of medical systems 2016;40:208. doi.org/10.1007/s10916-016-0569-3.
  • Fanciulli A, Gobel G, Ndayisaba JP, et al. Supine hypertension in Parkinson's disease and multiple system atrophy. Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2016;26:97-105. doi.org/10.1007/s10286-015-0336-4.
  • Ndayisaba JP, Fanciulli A, Granata R et. al. Sex and age effects on cardiovascular autonomic function in healthy adults. Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2015;25:317-326. doi.org/10.1007/s10286-015-0310-1.

Bis 2015

  • Struhal W, Mismas A, Kirchmayr M et.al. Onset of sweating depends on the type of reflex syncope. Autonomic neuroscience : basic & clinical 2014;184:73-76. doi.org/10.1016/j.autneu.2014.06.002.
  • Metzler M, Duerr S, Granata R et.at. Neurogenic orthostatic hypotension: pathophysiology, evaluation, and management. Journal of neurology 2013;260:2212-2219. doi.org/10.1007/s00415-012-6736-7.
  • Wenning GK, Granata R, Krismer F et.al. Orthostatic hypotension is differentially associated with the cerebellar versus the parkinsonian variant of multiple system atrophy: a comparative study. Cerebellum (London, England) 2012;11:223-226. doi.org/10.1007/s12311-011-0299-5.
  • Frauscher B, Nomura T, Duerr S et.al. Investigation of autonomic function in idiopathic REM sleep behavior disorder. Journal of neurology 2012;259:1056-1061. doi.org/10.1007/s00415-011-6298-0.
  • Pavy-Le Traon A, Amarenco G, Duerr S et.al. The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension. Movement disorders : official journal of the Movement Disorder Society 2011;26:1985-1992. doi.org/10.1002/mds.23742.
  • Fanciulli A, Strano S, Ndayisaba JP, et al. Detecting nocturnal hypertension in Parkinson's disease and multiple system atrophy: proposal of a decision-support algorithm. Journal of neurology 2014;261:1291-1299. doi.org/10.1007/s00415-014-7339-2.
  • Struhal W, Sellner J. European teaching course on autonomic nervous system disorders : reaching out to young physicians. Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2009;19:130. doi.org/10.1007/s10286-009-0523-2.
  • Peralta C, Stampfer-Kountchev M, Karner E et.al. Orthostatic hypotension and attention in Parkinson's disease with and without dementia. Journal of neural transmission (Vienna, Austria : 1996) 2007;114:585-588. doi.org/10.1007/s00702-006-0615-2.
  • Lahrmann H, Cortelli P, Hilz M et.al. EFNS guidelines on the diagnosis and management of orthostatic hypotension. European journal of neurology 2006;13:930-936. doi.org/10.1111/j.1468-1331.2006.01512.x.
  • Wenning GK, Scherfler C, Granata R et.al. Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. Journal of neurology, neurosurgery, and psychiatry 1999;67:620-623. https://www.ncbi.nlm.nih.gov/pubmed/10519868.